Publication | Closed Access

Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer's disease via the GLP-1R/SIRT1/GLUT4 pathway

Glp-1r/sirt1/glut4 PathwayAlzheimer's DiseaseG Protein-coupled ReceptorMedicineCell DeathGlucose Metabolism DysfunctionNeurochemical BiomarkersNeuroprotectionNeurosciencePharmacologyCell BiologyMouse Model